Arthritis Clinical Trials

If female, subject is either not of childbearing potential, defined as postmenopausal for at least 1 year or surgically sterile (bilateral tubal ligation, bilateral oophorectomy and/or hysterectomy) or is of childbearing potential and is practicing an approved method of birth control throughout the study and for 150 days after last dose of study drug. Examples of approved methods of birth control include the following (see local informed consent for more detail):

• Condoms, sponge, foams, jellies, diaphragm or intrauterine device (IUD);
• Hormonal contraceptives for 90 days prior to study drug administration;
• A vasectomized partner;